Remdesivir News and Research

RSS
Glucosidase inhibitors hold promise as novel therapeutic agents against SARS-CoV-2

Glucosidase inhibitors hold promise as novel therapeutic agents against SARS-CoV-2

Scientists develop experimental direct-acting antiviral therapy to treat COVID-19

Scientists develop experimental direct-acting antiviral therapy to treat COVID-19

ErbB inhibitor lapatinib exhibits potent anti-SARS-CoV-2 activity

ErbB inhibitor lapatinib exhibits potent anti-SARS-CoV-2 activity

Researchers use ultrasound to reduce COVID-19-related inflammation

Researchers use ultrasound to reduce COVID-19-related inflammation

Study reveals how oral antiviral drug works to attack SARS-CoV-2 virus

Study reveals how oral antiviral drug works to attack SARS-CoV-2 virus

Researchers design compounds that prevent SARS-CoV-2 entry in human lung cells

Researchers design compounds that prevent SARS-CoV-2 entry in human lung cells

Researchers discover the second possible effective mechanism of remdesivir

Researchers discover the second possible effective mechanism of remdesivir

Researchers identify anti-inflammatory prodrug Minnelide with potential against SARS-CoV-2

Researchers identify anti-inflammatory prodrug Minnelide with potential against SARS-CoV-2

Immunosuppression in COVID-19 promotes emergence of multiple immune escape mutants

Immunosuppression in COVID-19 promotes emergence of multiple immune escape mutants

Researchers identify potent small molecule TMPRSS2 inhibitor against SARS-CoV-2

Researchers identify potent small molecule TMPRSS2 inhibitor against SARS-CoV-2

Hepatitis C antivirals synergize with remdesivir to inhibit SARS-CoV-2 in vitro

Hepatitis C antivirals synergize with remdesivir to inhibit SARS-CoV-2 in vitro

What is the role of nanotechnology in the current COVID-19 outbreak?

What is the role of nanotechnology in the current COVID-19 outbreak?

The potential of CRISPR-based diagnostic assays and treatment approaches against COVID-19

The potential of CRISPR-based diagnostic assays and treatment approaches against COVID-19

New Phase 3 trial of therapeutics begins enrolling severely ill hospitalized COVID-19 patients

New Phase 3 trial of therapeutics begins enrolling severely ill hospitalized COVID-19 patients

Shifts in care due to COVID-19 pandemic likely to drive drug expenditures in 2021

Shifts in care due to COVID-19 pandemic likely to drive drug expenditures in 2021

NIH funds large Phase 3 clinical trial to test repurposed drugs for treating COVID-19 symptoms

NIH funds large Phase 3 clinical trial to test repurposed drugs for treating COVID-19 symptoms

Experimental antiviral drug for COVID-19 shows effectiveness in hamster models

Experimental antiviral drug for COVID-19 shows effectiveness in hamster models

No evidence B.1.1.7. variant worsens symptoms or increases risk of long COVID

No evidence B.1.1.7. variant worsens symptoms or increases risk of long COVID

Alpaca nanobodies effective against South African SARS-CoV-2 variant

Alpaca nanobodies effective against South African SARS-CoV-2 variant

Clinical trial of monoclonal antibody for treating respiratory disease in COVID-19 patients begins

Clinical trial of monoclonal antibody for treating respiratory disease in COVID-19 patients begins